The FDA Is Watching, Is Your Facility Ready?

For many food & dietary supplement manufacturers, the thought of an unannounced FDA inspection is enough to cause anxiety. And for good reason. An inspector can arrive without warning, request records, tour your facility, interview employees, and evaluate whether your operation complies with their regulations. 

Facilities that are unprepared risk receiving an FDA Form 483, which documents observed regulatory violations. While a Form 483 is not an enforcement action itself, it can trigger warning letters, product recalls, import restrictions, increased regulatory scrutiny, and in severe cases, facility shutdowns. Beyond regulatory consequences, compliance failures can damage customer trust and brand reputation.

Whether you’re launching your first product, scaling operations, or preparing for retail expansion, building a strong compliance program is one of the smartest investments you can make. Here’s how to prepare before the FDA comes knocking.

Step 1: Know the Regulations

The foundation of inspection readiness starts with understanding 21 CFR Part 117 (food) & 111 (dietary supplements) While the regulations are extensive, it establishes the requirements that manufacturers must follow to ensure products are consistently produced and controlled for quality.

Key requirements include:

• Maintaining complete production and quality control records
• Implementing sanitation, hygiene, and employee training programs
• Investigating and documenting product complaints
• Following written procedures for manufacturing, testing, packaging, labeling, and release activities
• Maintaining accurate Master Manufacturing Records (MMRs) and Batch Production Records (BPRs)
• Dietary Supplement: Verifying the identity, purity, strength, and composition of ingredients

FDA inspectors will evaluate both your documentation and your daily practices. Having procedures in place is important but consistently following them is what demonstrates compliance.

Step 2: Conduct a Compliance Audit Before FDA Does

Let’s face it, most companies don’t have the time to read and interpret every section of the regulations. Even organizations with experienced quality teams can overlook compliance gaps that become obvious during an FDA inspection.

A comprehensive compliance audit is one of the most effective ways to evaluate your readiness. Third-party audits provide an objective assessment of your facility, documentation, and quality systems against FDA expectations.

At Allay Consulting, our onsite and remote compliance audits are designed to mirror the depth and scope of an FDA inspection. During the assessment, we evaluate:

• Physical facility compliance assessments
• Production and process controls
• Employee quality control
• Quality systems and documentation
• Recordkeeping and traceability systems
• Complaint handling and corrective action procedures

Following the audit, you’ll receive a detailed report identifying compliance gaps, prioritized risks, and practical recommendations for corrective actions. Addressing issues proactively allows your team to strengthen compliance on your timeline, not during an FDA inspection.

Step 3: Train Your Team and Keep Documentation Inspection-Ready

Even facilities with strong quality systems can struggle during an inspection if employees are unsure of their responsibilities. Every team member should understand what to expect when an FDA investigator arrives.

Establish clear roles and responsibilities, including:

• Who greets the inspector
• Who serves as the primary company representative
• Who escorts inspectors through the facility
• Who retrieves records and documentation
• Who communicates responses to FDA questions

Consider conducting mock inspections to help employees become comfortable with the process and identify areas for improvement. 

Documentation should also be maintained in a state of continuous readiness. Standard Operating Procedures (SOPs), training records, batch records, calibration logs, complaint files, and quality control records should be current, organized, and readily accessible.

Inspection readiness is not a project that begins when FDA arrives, it’s a daily commitment to compliance.

Step 4: Consider cGMP Certification

One of the strongest indicators of regulatory readiness is achieving third-party cGMP certification. cGMP certification demonstrates that your facility has implemented a structured quality management system designed to consistently produce safe and compliant products. Certification programs assess the same foundational elements FDA inspectors evaluate, including documentation, quality oversight, production controls, training, sanitation, and recordkeeping.

The certification process requires organizations to establish and maintain documented procedures that govern every stage of manufacturing, from raw material receipt and testing through packaging, storage, and product release.

Benefits of cGMP certification include:

• Improved inspection readiness
• Stronger quality systems and operational controls
• Increased customer and consumer confidence
• Enhanced supplier and retailer credibility
• Access to new distribution opportunities

Many major retailers and marketplaces (including Walmart, CVS, and Amazon) either require or strongly prefer suppliers with recognized cGMP certifications. 

Most importantly, certification helps transform compliance from a reactive exercise into a proactive business strategy.

Be Ready Before FDA Arrives

The FDA doesn’t schedule inspections around your calendar. The best time to prepare is before an investigator arrives at your door. By understanding FDA’s CFR 117 and/or 111 requirements, conducting regular compliance audits, maintaining robust documentation, training employees, and implementing strong cGMP systems, your organization can approach inspections with confidence instead of concern.

Preparation isn’t just about avoiding a Form 483, it’s about protecting your products, your customers, and your brand.